GyroGlove Use in Essential Tremor Patients (NCT05958030)
Effectiveness and Safety of GyroGlove in Stabilising Hand Tremors in Essential Tremor
🩺 Plain-English Summary (8th-Grade Level)
This is a multi-centre, single-blind, placebo-controlled trial with an open label follow up. After the baseline assessment, all participants will receive the GyroGlove for two weeks during the open label follow up part of the trial. All gloves will be retrieved and returned to GyroGear after closure of the study.
Who can join: Review the eligibility criteria below.
Location: Quest Research Institute — Farmington Hills, Michigan
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Quest Research Institute — Farmington Hills, Michigan
- Houston Methodist Stanley H. Appel Department of Neurology — Houston, Texas
- University of Vermont Medical Centre — Burlington, Vermont
- Addenbrooke Hospital, Cambridge University Hospital NHS Trust — Cambridge, England
- Clinical Ageing Research Unit, Newcastle University — Newcastle, England
- Oxford University Hospitals NHS Foundation Trust, UK — Oxford, England
- North Tyneside General Hospital — Newcastle,
📞 Contact the Study Coordinator
Phone: +44 2045773038
Email: clinical@gyrogear.co
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Essential Tremor
- Long-Term Transcutaneous Stimulation and Essential Tremor: A PET Study — Rochester, Minnesota
- Bilateral Treatment of Medication Refractory Essential Tremor — Stanford, California
- Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) — Morgantown, West Virginia
- RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease — Birmingham, Alabama
- Responsive Deep Brain Stimulator for Essential Tremor — Gainesville, Florida
- Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders: — Stanford, California
Explore by condition: All Essential Tremor clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.